Mei‐Zhen Wu

812 total citations
72 papers, 490 citations indexed

About

Mei‐Zhen Wu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Mei‐Zhen Wu has authored 72 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 17 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Epidemiology. Recurrent topics in Mei‐Zhen Wu's work include Cardiovascular Function and Risk Factors (16 papers), Cardiac Valve Diseases and Treatments (13 papers) and Diabetes Treatment and Management (12 papers). Mei‐Zhen Wu is often cited by papers focused on Cardiovascular Function and Risk Factors (16 papers), Cardiac Valve Diseases and Treatments (13 papers) and Diabetes Treatment and Management (12 papers). Mei‐Zhen Wu collaborates with scholars based in China, Hong Kong and Singapore. Mei‐Zhen Wu's co-authors include Kai‐Hang Yiu, Q W Ren, Hung‐Fat Tse, Carolyn S.P. Lam, Hang‐Long Li, Pui‐Fai Wong, Hung‐Fat Tse, Tiew‐Hwa Katherine Teng, Yi-Kei Tse and LM Ho and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mei‐Zhen Wu

64 papers receiving 484 citations

Peers

Mei‐Zhen Wu
L. Joost van Pelt Netherlands
Mei‐Zhen Wu
Citations per year, relative to Mei‐Zhen Wu Mei‐Zhen Wu (= 1×) peers L. Joost van Pelt

Countries citing papers authored by Mei‐Zhen Wu

Since Specialization
Citations

This map shows the geographic impact of Mei‐Zhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Zhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Zhen Wu more than expected).

Fields of papers citing papers by Mei‐Zhen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Zhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Zhen Wu. The network helps show where Mei‐Zhen Wu may publish in the future.

Co-authorship network of co-authors of Mei‐Zhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Zhen Wu. A scholar is included among the top collaborators of Mei‐Zhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Zhen Wu. Mei‐Zhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Mei‐Zhen, Ran Guo, Chanchal Chandramouli, et al.. (2025). Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. European Heart Journal.
2.
Wu, Mei‐Zhen, Tsz Hon Yuen, & Siu Ming Yiu. (2025). Efficient Private Set Intersection by Utilizing Oblivious Transfer Extension. Monash University Research Portal (Monash University). 104–117.
3.
Teng, Tiew‐Hwa Katherine, Wouter Ouwerkerk, Yi-Kei Tse, et al.. (2025). Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure. Nature Communications. 16(1). 1408–1408. 5 indexed citations
4.
Huang, Jiayi, Anping Cai, Mei‐Zhen Wu, et al.. (2024). The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants. European Journal of Preventive Cardiology. 31(18). 2073–2083. 1 indexed citations
5.
Cheang, Iokfai, Xu Zhu, Jiayi Huang, et al.. (2024). Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines. Cancer. 130(16). 2795–2806. 2 indexed citations
6.
Xu, Xin, Q W Ren, Chanchal Chandramouli, et al.. (2024). Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status. Journal of the American Heart Association. 13(9). e034109–e034109. 1 indexed citations
7.
Wei, Yunwei, Bai Cui, Shuying Xu, et al.. (2024). Diagnostic and Predictive Value of LncRNA MCM3AP-AS1 in Sepsis and Its Regulatory Role in Sepsis-Induced Myocardial Dysfunction. Cardiovascular Toxicology. 24(10). 1125–1138. 3 indexed citations
8.
Fan, Hong-Qiang, Fei Li, Hongxing Zheng, et al.. (2024). Multiple factors influencing high-purity indium electrolytic refining. Chinese Journal of Chemical Engineering. 71. 148–160. 2 indexed citations
9.
Fan, Hong-Qiang, Hongxing Zheng, Peng Lu, et al.. (2023). Machine learning-based multi-objective parameter optimization for indium electrorefining. Separation and Purification Technology. 328. 125092–125092. 6 indexed citations
10.
Ren, Q W, Tiew‐Hwa Katherine Teng, Yi-Kei Tse, et al.. (2023). Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure. JACC Asia. 3(1). 108–119. 9 indexed citations
11.
Huang, Junjie, Meiling Wu, Ming‐Yen Ng, et al.. (2023). Interaction between uric acid and obesity with myocardial dysfunction in diabetes. European Heart Journal - Cardiovascular Imaging. 24(Supplement_1).
12.
Wu, Mei‐Zhen, et al.. (2023). Purification of High-Purity Tin via Vertical Zone Refining. Separations. 10(7). 380–380. 2 indexed citations
13.
Chan, Yap‐Hang, Yan Chen, Mei‐Zhen Wu, et al.. (2022). Osteogenic Circulating Endothelial Progenitor Cells are Associated with Vascular Aging of the Large Arteries in Rheumatoid Arthritis. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Chandramouli, Chanchal, Hang‐Long Li, Mei‐Zhen Wu, et al.. (2022). Concomitant Hepatorenal Dysfunction and Malnutrition in Valvular Heart Surgery: Long‐Term Prognostic Implications for Death and Heart Failure. Journal of the American Heart Association. 11(10). e024060–e024060. 1 indexed citations
15.
Lee, Chi‐Ho, Mei‐Zhen Wu, David Tak Wai Lui, et al.. (2022). Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. 46(6). 843–854. 12 indexed citations
16.
Li, Hang‐Long, Yi-Kei Tse, Xue Li, et al.. (2022). Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis. Mayo Clinic Proceedings. 98(2). 252–265. 4 indexed citations
17.
Wu, Mei‐Zhen, Chanchal Chandramouli, Pui‐Fai Wong, et al.. (2022). Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors. Diabetes & Metabolism. 48(6). 101367–101367. 26 indexed citations
18.
Li, Hang‐Long, Gregory Y.H. Lip, Qi Feng, et al.. (2021). Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis. Cardiovascular Diabetology. 20(1). 177–177. 2 indexed citations
19.
Goldberg, Shalom D., Christopher S. Theile, Kathleen Haskell, et al.. (2021). Centyrin ligands for extrahepatic delivery of siRNA. Molecular Therapy. 29(6). 2053–2066. 33 indexed citations
20.
Chen, Yan, et al.. (2020). The Prevalence, Predictors, and Prognosis of Tricuspid Regurgitation in Stage B and C Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 7(6). 4051–4060. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026